8 October 2015 - Praluent and Repatha will be available to patients through the Accredo Specialty Pharmacy, where patients will have 24/7 access to PCSK9 specialist pharmacists and nurses who will help them use these injectable drugs properly, remain adherent to the therapy and achieve optimal health outcomes.

For more details, go to: http://lab.express-scripts.com/insights/drug-options/both-pcsk9-inhibitors-included-on-national-preferred-formulary